Inventor
BLANCHETOT CHRISTOPHE
BE23 patents
⚠️ This page may combine multiple inventors who share the name “BLANCHETOT CHRISTOPHE”. Patents are grouped by organization below to help distinguish them — per-person disambiguation is on the roadmap.
argenx BV
9 patentsUS11505585B2Nov 22, 2022
FcRn antagonists and methods of use
argenx BV7 citations83
US12344678B2Jul 1, 2025
FcRn/HSA binding molecules and methods of use
argenx BV3 citations69
US11708403B2Jul 25, 2023
Antibodies to human complement factor C2B and methods of use
argenx BV0 citations62
US11591386B2Feb 28, 2023
Antibodies to human complement C2B
argenx BV0 citations62
US11827701B2Nov 28, 2023
IL-6 binding molecules
argenx BV0 citations59
US12565538B2Mar 3, 2026
FCRN/antigen-binding molecules and methods of use
argenx BV0 citations57
US12030949B2Jul 9, 2024
Multispecific antibodies against IL-5 and IL-4R
argenx BV0 citations53
US12071486B2Aug 27, 2024
Bispecific antigen binding construct
argenx BV0 citations50
US12060413B2Aug 13, 2024
Method of preparing pH-dependent antibodies
argenx BV0 citations43
BLANCHETOT CHRISTOPHE
4 patentsUS8906680B2Dec 9, 2014
Amino acid sequences directed against chemokines and polypeptides comprising the same for the treatment of chemokine-related diseases and disorders
BLANCHETOT CHRISTOPHE11 citations83
US9005963B2Apr 14, 2015
Amino acid sequences directed against cellular receptors for viruses and bacteria
BLANCHETOT CHRISTOPHE13 citations82
US9156914B2Oct 13, 2015
Amino acid sequences directed against a metalloproteinase from the ADAM family and polypeptides comprising the same for the treatment of ADAM-related diseases and disorders
BLANCHETOT CHRISTOPHE4 citations72
US9212226B2Dec 15, 2015
Amino acid sequences directed against CXCR4 and other GPCRs and compounds comprising the same
BLANCHETOT CHRISTOPHE5 citations70
ARGENX BVBA
3 patentsARGEN X N V
2 patentsABLYNX NV
2 patentsUS9803018B2Oct 31, 2017
Amino acid sequences directed against cellular receptors for viruses and bacteria
ABLYNX NV2 citations71
US9512236B2Dec 6, 2016
Amino acid sequences directed against GPCRS and polypeptides comprising the same for the treatment of GPCR-related diseases and disorders
ABLYNX NV0 citations38